Risk factors for postoperative recurrence of sacral chordoma: an eleven-year single-centre retrospective study
International Orthopaedics · 2026-12 · 50 (12) · 3263-3270
DOI: 10.1007/s00264-026-07058-w ↗Kurz gefasst
Fachartikel in der Zeitschrift International Orthopaedics, online erschienen am 12.10.2026. Verfasst von Xinhui Du und 4 weiteren Autor:innen. Beteiligte Einrichtung: Bone and Soft Tissue Department, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China. drduxinhui@163.com. Hauptthemen laut MEDLINE: Chordoma, Sacrum, Neoplasm Recurrence, Local, Spinal Neoplasms. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Science and Technology Research Project of Henan Province.
Abstract (Originalsprache)
Purpose
Chordoma is a rare, low-grade malignant bone tumour that most commonly arises in the sacrococcygeal region. Reported prognostic factors for recurrence are inconsistent and the role of postoperative adjuvant treatment is undefined. We investigated risk factors for recurrence in a consecutive single-centre cohort of sacral chordoma in which R0 resection was achieved in every patient.
Methods
We retrospectively reviewed 34 consecutive patients with sacral chordoma treated with curative resection at our centre between 2013 and 2024. Clinical, surgical, adjuvant and follow-up data were recorded. Recurrence-free survival (RFS) was estimated using the Kaplan–Meier method, and independent risk factors for recurrence were identified using multivariate Cox regression.
Results
The cohort comprised 24 men and ten women (mean age 62.1 years). Recurrence occurred in 19 of 34 patients (55.9%) after a median follow-up of 36 months; median RFS was 33 months (95% CI 16.7–49.3) and nine patients (47.4%) developed distant metastases. Maximum tumour diameter ≥ 65 mm (HR 3.42, 95% CI 1.18–9.92; p = 0.024) and a history of previous surgery (HR 4.57, 95% CI 1.52–13.73; p = 0.007) were independent risk factors for recurrence, whereas postoperative targeted therapy was associated with lower recurrence risk (HR 0.31, 95% CI 0.10–0.94; p = 0.038).
Conclusion
Recurrence of sacral chordoma was common even after R0 resection. Large tumour diameter and previous surgery were independent risk factors for recurrence. The association between postoperative targeted therapy and lower recurrence risk should be interpreted with caution because treatment was not randomised.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bone and Soft Tissue Department, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China. drduxinhui@163.com.
- Department of Anaesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Bone and Soft Tissue Department, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
- Bone and Soft Tissue Department, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China. zlyyywt1402@zzu.edu.cn.
Förderung
- Science and Technology Research Project of Henan Province
Zitieren
APA
Du, X., Wei, H., Zhang, B., Liang, X., & Yao, W. (2026). Risk factors for postoperative recurrence of sacral chordoma: an eleven-year single-centre retrospective study. International Orthopaedics, 50(12), 3263-3270. https://doi.org/10.1007/s00264-026-07058-w
Vancouver
Du X, Wei H, Zhang B, Liang X, Yao W. Risk factors for postoperative recurrence of sacral chordoma: an eleven-year single-centre retrospective study. International Orthopaedics. 2026;50(12):3263-3270. doi:10.1007/s00264-026-07058-w
BibTeX
@article{Du2026,
author = {Du, Xinhui and Wei, Hua and Zhang, Boya and Liang, Xiaoxiao and Yao, Weitao},
title = {Risk factors for postoperative recurrence of sacral chordoma: an eleven-year single-centre retrospective study},
journal = {International Orthopaedics},
year = {2026},
volume = {50},
number = {12},
pages = {3263--3270},
doi = {10.1007/s00264-026-07058-w}
}
EUVIMED